960535-44-8

Basic information

• Product Name: Thiazolo[4,5-b]pyridine, 6-bromo-2-chloro-
• CAS NO: 960535-44-8
• Molecular Formula: C6H2BrClN2S
• Molecular Weight: 249.518
• Mol File: 960535-44-8.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Thiazolo[4,5-b]pyridine, 6-bromo-2-chloro-(CAS DataBase Reference)
• NIST Chemistry Reference: Thiazolo[4,5-b]pyridine, 6-bromo-2-chloro-(960535-44-8)
• EPA Substance Registry System: Thiazolo[4,5-b]pyridine, 6-bromo-2-chloro-(960535-44-8)

Safety Data

• Hazardous Substances Data: 960535-44-8(Hazardous Substances Data)

Upstream product

• 35486-42-1 2-amino-3,5-dibromopyridine 
• 140-89-6 potassium ethyl xanthogenate 
• 194668-71-8 6-bromothiazolo[4,5-b]pyridine-2(3H)-thione 
• 588729-97-9 N-(6-bromo[1,3]thiazolo[4,5-b]pyridin-2-yl)benzamide 
• 381233-96-1 2-amino-3-iodo-5-bromopyridine 
• 857970-06-0 2-amino-6-bromo[1,3]thiazolo[4,5-b]pyridine 
• 31430-58-7 N-[(3,5-dibromopyridin-2-yl)carbamothioyl]benzamide 
• 31545-35-4 1-(3,5-dibromopyridin-2-yl)thiourea 

Relevant articles and documents

HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted benzothiazole compounds of Formula (I) or (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

1, 3, 4, 5-TETRAHYDRO-2H-PYRIDO[4,3-B]INDOLE DERIVATIVES FOR THE TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES LIKE ALZHEIMER'S DISEASE

The present invention relates to novel compounds that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).

NOVEL BICYCLIC HETEROCYCLIC COMPOUND

Provided are a novel compound having a superior inhibitory action on KAT-II, a production method thereof, use thereof, and a pharmaceutical composition containing the aforementioned compound and the like. A compound represented by the formula (I) or a pharmacologically acceptable salt thereof. wherein each symbol is as defined in the DESCRIPTION.